Diallyllysergamide

chemical compound

Uses your system voice; voice and rate in settings.

Q5270572Snapshot

≈ 1 min read

Names in other languages

  • EnglishDiallyllysergamide
  • shDialilisergamid
  • СрпскиDialilisergamid

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

N,N-Diallyllysergamide (DAL), also known as lysergic acid diallylamide (LDA), is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is taken orally.

Use and effects

In his 1997 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin described DAL as producing "at best a touch of sparkle" of LSD at dose of 600 μg of the tartrate salt taken orally, but as also producing a sedation. Subsequently, in a 2003 literature review, Shulgin listed an active dose as greater than 1 mg. He has described the drug as being at least an order of magnitude less potent than LSD.

Pharmacodynamics

DAL interacts with serotonin receptors, including the serotonin 5-HT 1A , 5-HT 2A , and 5-HT 2C receptors. It acts as a serotonin 5-HT 2A receptor agonist, but with about 5-fold lower potency than LSD.

See also

Substituted lysergamide Lysergic acid dimethylamide (DAM-57) Lysergic acid dipropylamide (DPL) Lysergic acid dibutylamide (LBB-66) Substituted tryptamine

DAL - Isomer Design LSD-25 (Discusses DAL) - TiHKAL - Erowid LSD-25 (Discusses DAL) - TiHKAL - Isomer Design

Text derived from https://en.wikipedia.org/w/index.php?oldid=1341406349 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.